566
+1.80%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Pharma Foods International Co
Its shares trade on Tokyo Stock Exchange under the ticker 2929.T. It has been listed since 12 June 2006. In the fiscal year to 31 July 2026, it reported revenue of ¥63.22bn and net income of ¥1.99bn. At that date it held total assets of ¥35.12bn and shareholders' equity of ¥13.17bn.
Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 12 Jun 2006
- Employees
- 670
- Website
- pharmafoods.co.jp ↗
Leadership
Pay as last reported
- Mr. Mujo KimPresident, Chief Executive Officer, Representative Director, since 1999
- Mr. Kazuyuki MasudaSenior Managing Director, President of Subsidiaries, since 2008
- Mr. Hirotaka HigashiyamaDirector of Biomedical Unit, Director, since 2023
- Mr. Yongiru KimDirector
- Ms. Yukako HayashiIndependent Director
- Mr. Shinya SamuraIndependent Director
- Mr. Taro UedaIndependent Director
- Mr. Tetsuro YamaneIndependent Director
- Mr. Toshihiro KawanakaDirector of Business Planning, since 2024
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Pharma Foods International employs 670 full-time staff members in Kyoto.
- The company operates three distinct business segments for diversified revenue.
- Tamagosamin supplements are sold through television and radio advertising media.
Weaknesses
- The company is headquartered in Kyoto, Kyoto-Fu, Japan.
- Pharma Foods International went public on 12 June 2006.
- The firm relies on advertising media for its Mail Order segment.
Opportunities
- The Functional Materials segment develops GABA and Bonepep products.
- Chicken Egg Antibody materials are sold in the Functional Materials segment.
- OEM products include supplements and beverages for original equipment manufacturers.
Threats
- The Biomedical segment engages in antibody contract manufacture for drug discovery.
- Life science information business provides analysis for efficacy evaluation tests.
- Pearl Skin Lanchel cosmetics are sold via the Mail Order segment.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.